|
Pregnancy Concerns Weigh Heavy on Female RA Patients
|
Women with rheumatoid arthritis are concerned with pregnancy and parenting issues and require more information from their doctors, say researchers writing in ACR Open Rheumatology this month.
|
|
Read more
|
| |
|
Adalimumab Biosimilar Post-Marketing Report
|
An Indian-made biosimilar to adalimumab has been shown to be safe and effective for up to 24 weeks in patients with ankylosing spondylitis, say researchers writing in ACR Open Rheumatology this month.
|
|
Read more
|
|
|
|
New JAK Inhibitor Approved for Rheumatoid Arthritis
|
AbbVie announced on Friday that the Food and Drug Administration approved the oral once-daily JAK inhibitor Rinvoq (upadacitinib) for adults with
moderate to severe active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate.
|
|
Read more
|
